EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Telehealth follow‐up consultations for melanoma patients during the COVID‐19 pandemic: Patient and clinician satisfaction

Ali Al-Rikaby, Ahmad Sulaiman, Jake R Thompson iD, Robyn P M Saw, Frances Boyle, Nicole Taylor, Matteo S Carlino, Rachael L Morton, Omgo E Nieweg, John F Thompson, Iris Bartula iD

Cancer Medicine · 2023

DOI: 10.1002/cam4.6679 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Ali Al-Rikaby und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: COVID-19, Melanoma, Telemedicine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Friends of The Mater Foundation, National Health and Medical Research Council, The Bill and Patricia Ritchie Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The COVID‐19 pandemic caused rapid implementation of telehealth for melanoma follow‐up care in Australia. This study explores Australian melanoma patients and clinicians' level of satisfaction with telehealth.

Methods

A cross‐sectional study was conducted across three specialist melanoma centres in Sydney, Australia. Melanoma patients (all stages) and clinicians completed mixed methods surveys seeking socio‐demographic and clinical information and questionnaires to assess satisfaction with telehealth. Additionally, patients completed measures of quality of life, fear of cancer recurrence and trust in their oncologist. Patients and clinicians provided open‐ended responses to qualitative questions about their perceptions of telehealth.

Results

One hundred and fifteen patients and 13 clinicians responded to surveys. Telephone was used by 109 (95%) patients and 11 (85%) clinicians. Fifty‐seven (50%) patients and nine (69%) clinicians preferred face‐to‐face consultations, 38 (33%) patients and 3 (23%) clinicians preferred a combination of face‐to‐face and telehealth consultations. Five (4%) patients and nil clinicians preferred telehealth consultations. Patients diagnosed with early‐stage melanoma, using telehealth for the first time, who have lower trust in their oncologist, and having higher care delivery, communication and supportive care concerns were likely to report lower satisfaction with telehealth. Open‐ended responses were consistent between patients and clinicians, who reported safety, convenience and improved access to care as major benefits, while identifying personal, interpersonal, clinical and system‐related disadvantages.

Discussion

While telehealth has been widely implemented during COVID‐19, the benefits identified by patients and clinicians may extend past the pandemic. Telehealth may be considered for use in conjunction with face‐to‐face consultations to provide melanoma follow‐up care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19MelanomaTelemedicineHumansPatient SatisfactionPandemicsCross-Sectional StudiesFollow-Up StudiesQuality of LifeAustraliaReferral and ConsultationPersonal Satisfaction

Stichwörter der Autor:innen

COVID-19melanomasatisfactionsupportive caretelehealth

Autor:innen und Institutionen

  • Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Melanoma Institute Australia, The University of Sydney, North Sydney, New South Wales, Australia.
  • Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
  • Patricia Ritchie Centre for Cancer Care and Research, Mater Hospital, North Sydney, New South Wales, Australia.
  • Department of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia.
  • NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Camperdown, Sydney, New South Wales, Australia.

ORCID-Profile: Jake R Thompson, Iris Bartula

Förderung

  • Friends of The Mater Foundation
  • National Health and Medical Research Council
  • The Bill and Patricia Ritchie Foundation
  • University of Sydney

Zitieren

APA

Al-Rikaby, A., Sulaiman, A., Thompson, J. R., Saw, R. P. M., Boyle, F., Taylor, N., Carlino, M. S., Morton, R. L., Nieweg, O. E., Thompson, J. F., & Bartula, I. (2023). Telehealth follow‐up consultations for melanoma patients during the COVID‐19 pandemic: Patient and clinician satisfaction. Cancer Medicine. https://doi.org/10.1002/cam4.6679

Vancouver

Al-Rikaby A, Sulaiman A, Thompson JR, Saw RPM, Boyle F, Taylor N, et al. Telehealth follow‐up consultations for melanoma patients during the COVID‐19 pandemic: Patient and clinician satisfaction. Cancer Medicine. 2023. doi:10.1002/cam4.6679

BibTeX
@article{AlRikaby2023,
  author = {Al-Rikaby, Ali and Sulaiman, Ahmad and Thompson, Jake R and Saw, Robyn P M and Boyle, Frances and Taylor, Nicole and Carlino, Matteo S and Morton, Rachael L and Nieweg, Omgo E and Thompson, John F and Bartula, Iris},
  title = {Telehealth follow‐up consultations for melanoma patients during the COVID‐19 pandemic: Patient and clinician satisfaction},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.6679}
}
Kostenlos starten →